Michael Luong, Minlei Zhang, Ihor Djura, Ying Wang, Alison Joyce
{"title":"利用链亲和素PhyTip®色谱柱在免疫原性试验中进行样品预处理的抗药物抗体富集自动化。","authors":"Michael Luong, Minlei Zhang, Ihor Djura, Ying Wang, Alison Joyce","doi":"10.1208/s12248-025-01092-z","DOIUrl":null,"url":null,"abstract":"<p><p>The administration of biotherapeutics has the potential to induce potent immune responses, including the induction of anti-drug antibodies (ADA) (1). Detection and characterization of ADA in clinical trials is an important component of a comprehensive immunogenicity program (2). ADA testing is mostly accomplished with ligand-binding assays (LBA). While LBA can be robust and specific, they are susceptible to various sources of interference (3). Of particular concern, interference from residual drug present in patient samples may lead to loss of ADA detection, producing false negative results. To mitigate drug interference, sample pretreatment procedures have been developed to enrich ADA from samples with high drug concentrations (4, 5). The pretreatment procedures can vary considerably but typically involve an initial step to liberate ADA from ADA-drug complexes and a subsequent step to affinity capture ADA and acid elute for detection. While these procedures can be highly effective, they have certain drawbacks when performed manually. First, the procedures are time-consuming and require near constant attention. Second, because of the manual workflow, the procedures can produce variable results between experiments and between different analysts with negative consequences for assay robustness. To address these drawbacks, we developed an automated procedure to enrich ADA by leveraging dual flow chromatography (DFC) and Streptavidin PhyTip® columns on a liquid-handling system (6). The enriched ADA were then tested in an LBA to evaluate the effectiveness of the automated enrichment procedure.</p>","PeriodicalId":50934,"journal":{"name":"AAPS Journal","volume":"27 4","pages":"108"},"PeriodicalIF":5.0000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Automation of Anti-Drug Antibody Enrichment Using Streptavidin PhyTip® Columns for Sample Pretreatment in an Immunogenicity Assay.\",\"authors\":\"Michael Luong, Minlei Zhang, Ihor Djura, Ying Wang, Alison Joyce\",\"doi\":\"10.1208/s12248-025-01092-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The administration of biotherapeutics has the potential to induce potent immune responses, including the induction of anti-drug antibodies (ADA) (1). Detection and characterization of ADA in clinical trials is an important component of a comprehensive immunogenicity program (2). ADA testing is mostly accomplished with ligand-binding assays (LBA). While LBA can be robust and specific, they are susceptible to various sources of interference (3). Of particular concern, interference from residual drug present in patient samples may lead to loss of ADA detection, producing false negative results. To mitigate drug interference, sample pretreatment procedures have been developed to enrich ADA from samples with high drug concentrations (4, 5). The pretreatment procedures can vary considerably but typically involve an initial step to liberate ADA from ADA-drug complexes and a subsequent step to affinity capture ADA and acid elute for detection. While these procedures can be highly effective, they have certain drawbacks when performed manually. First, the procedures are time-consuming and require near constant attention. Second, because of the manual workflow, the procedures can produce variable results between experiments and between different analysts with negative consequences for assay robustness. To address these drawbacks, we developed an automated procedure to enrich ADA by leveraging dual flow chromatography (DFC) and Streptavidin PhyTip® columns on a liquid-handling system (6). The enriched ADA were then tested in an LBA to evaluate the effectiveness of the automated enrichment procedure.</p>\",\"PeriodicalId\":50934,\"journal\":{\"name\":\"AAPS Journal\",\"volume\":\"27 4\",\"pages\":\"108\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AAPS Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1208/s12248-025-01092-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AAPS Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1208/s12248-025-01092-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Automation of Anti-Drug Antibody Enrichment Using Streptavidin PhyTip® Columns for Sample Pretreatment in an Immunogenicity Assay.
The administration of biotherapeutics has the potential to induce potent immune responses, including the induction of anti-drug antibodies (ADA) (1). Detection and characterization of ADA in clinical trials is an important component of a comprehensive immunogenicity program (2). ADA testing is mostly accomplished with ligand-binding assays (LBA). While LBA can be robust and specific, they are susceptible to various sources of interference (3). Of particular concern, interference from residual drug present in patient samples may lead to loss of ADA detection, producing false negative results. To mitigate drug interference, sample pretreatment procedures have been developed to enrich ADA from samples with high drug concentrations (4, 5). The pretreatment procedures can vary considerably but typically involve an initial step to liberate ADA from ADA-drug complexes and a subsequent step to affinity capture ADA and acid elute for detection. While these procedures can be highly effective, they have certain drawbacks when performed manually. First, the procedures are time-consuming and require near constant attention. Second, because of the manual workflow, the procedures can produce variable results between experiments and between different analysts with negative consequences for assay robustness. To address these drawbacks, we developed an automated procedure to enrich ADA by leveraging dual flow chromatography (DFC) and Streptavidin PhyTip® columns on a liquid-handling system (6). The enriched ADA were then tested in an LBA to evaluate the effectiveness of the automated enrichment procedure.
期刊介绍:
The AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists (AAPS), publishes novel and significant findings in the various areas of pharmaceutical sciences impacting human and veterinary therapeutics, including:
· Drug Design and Discovery
· Pharmaceutical Biotechnology
· Biopharmaceutics, Formulation, and Drug Delivery
· Metabolism and Transport
· Pharmacokinetics, Pharmacodynamics, and Pharmacometrics
· Translational Research
· Clinical Evaluations and Therapeutic Outcomes
· Regulatory Science
We invite submissions under the following article types:
· Original Research Articles
· Reviews and Mini-reviews
· White Papers, Commentaries, and Editorials
· Meeting Reports
· Brief/Technical Reports and Rapid Communications
· Regulatory Notes
· Tutorials
· Protocols in the Pharmaceutical Sciences
In addition, The AAPS Journal publishes themes, organized by guest editors, which are focused on particular areas of current interest to our field.